Showing results (181-190 of 265) with videos related to

Sort By:
Pageof 27
Journal of Acquired Immune Deficiency Syndromes (1999)|June 19, 2001
Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in SpainN Benito, A Rañó, A Moreno, et al.
The European Respiratory Journal|November 1, 1995
Aetiology and prognostic factors of patients with AIDS presenting life-threatening acute respiratory failureA Torres, M El-Ebiary, R Marrades, et al.
The Journal of Antimicrobial Chemotherapy|September 15, 2016
Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infectionJ Ambrosioni, D Nicolás, C Manzardo, et al.
Chemotherapy|January 1, 1989
Ceftriaxone monotherapy for severe bacteremic infections. Spanish Ceftriaxone Study GroupE Soriano, J M Gatell, J M Aguado, et al.
Journal of Viral Hepatitis|September 19, 2007
Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfectionM Ramos-Casals, X Forns, P Brito-Zerón, et al.
HIV Medicine|November 17, 2004
Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA studyA Mocroft, A d'Arminio Monforte, O Kirk, et al.
Medicina Clinica|January 28, 1995
[Intestinal microsporidiosis in patients with AIDS: study of 3 cases]O Miró, A Moreno, M E Valls, et al.
Presse Medicale (Paris, France : 1983)|December 24, 1983
[Paroxysmal atrioventricular block, cause of syncope in pulmonary embolism. 2 cases]C Wilner, J P Garnier-Crussard, A Huygue De Mahenge, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 28, 2003
Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patientsP García de Olalla, M A Martínez-González, J A Caylà, et al.
The New England Journal of Medicine|July 29, 1993
Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative GroupD A Cooper, J M Gatell, S Kroon, et al.
Pageof 27